Indian auto ancillaries witnessed robust revenue growth of 12.5% in FY26, driven by strong volumes and a better product mix. While EBITDA a...

ITC's business with major shareholder British American Tobacco (BAT) saw a 10% expansion in sales to Rs 1,587 crore in FY26, though dividen...

India's fiscal deficit is expected to remain under control in FY27, thanks to robust nominal GDP growth driven by higher inflation, accordi...

Nomura expects consumer staples to deliver a strong start to FY27, forecasting double-digit sales growth for several companies in the June ...

Goldman Sachs has raised India's 2026 real GDP growth forecast to 6.8% from 6.5%, citing lower oil prices, easing supply disruptions and re...

Affordable housing finance companies are poised for a growth rebound from FY27, according to Kotak Institutional Securities. After a subdue...

At first glance, this auto ancillary company looks like a conventional two-wheeler supplier. But its business mix tells a wider story. A ne...

Brokerages remain divided on two stocks. Goldman Sachs retained its 'Sell' rating on Bharat Dynamics, raising the target price marginally t...

Trent's stock surged over 4% as brokerages like Morgan Stanley and Motilal Oswal reiterated bullish calls. Chairman Noel Tata's vision of 1...

Nomura remains positive on Anant Raj despite trimming earnings estimates and lowering its target price due to slower cloud ramp-up and proj...

Brokerages are bullish on select retail, defence, and auto stocks, citing strong growth prospects. Morgan Stanley backs Trent's aggressive ...

Public sector banks are losing ground in the gold loan market to private lenders and NBFCs, which offer faster service and wider reach. Whi...

Brokerages are selectively backing consumer, logistics, and e-commerce firms with strong growth prospects. Citi initiates coverage on Meesh...

International brokerage Citi initiated coverage on Meesho with a 'Buy' rating, setting a target price of Rs 210 and anticipating a 23% upsi...

Bharat Electronics shares are in focus following a significant Rs 1,081 crore order win, adding to previous gains. The defence PSU reported...

Brokerage views on Indian equities are mixed as Morgan Stanley raises Nykaa's target price on ambitious FY30 growth plans. Conversely, conc...

Dabur India shares are set to be in focus after the US FDA issued an import alert on drugs manufactured at its Silvassa plant, citing data ...